Symbol:
LRIG3
Name:
leucine rich repeats and immunoglobulin like domains 3
RGD ID:
1347856
HGNC Page
HGNC:30991
Description:
Predicted to act upstream of or within otolith morphogenesis. Located in extracellular space.
Type:
protein-coding
RefSeq Status:
VALIDATED
Previously known as:
FLJ26573; FLJ90440; KIAA3016; leucine-rich repeats and immunoglobulin like domains 3; leucine-rich repeats and immunoglobulin-like domains 3; leucine-rich repeats and immunoglobulin-like domains protein 3; LIG-3; LIG3
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Mus musculus (house mouse):
Lrig3 (leucine-rich repeats and immunoglobulin-like domains 3)
HGNC
EggNOG, Ensembl, HGNC, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, OrthoMCL, Panther, PhylomeDB, Treefam
Rattus norvegicus (Norway rat):
Lrig3 (leucine-rich repeats and immunoglobulin-like domains 3)
HGNC
Ensembl, HomoloGene, NCBI, OrthoDB, Panther, Treefam
Chinchilla lanigera (long-tailed chinchilla):
Lrig3 (leucine rich repeats and immunoglobulin like domains 3)
NCBI
Ortholog
Pan paniscus (bonobo/pygmy chimpanzee):
LRIG3 (leucine rich repeats and immunoglobulin like domains 3)
NCBI
Ortholog
Canis lupus familiaris (dog):
LRIG3 (leucine rich repeats and immunoglobulin like domains 3)
HGNC
EggNOG, Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, OrthoMCL, Panther, PhylomeDB, Treefam
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
Lrig3 (leucine rich repeats and immunoglobulin like domains 3)
NCBI
Ortholog
Sus scrofa (pig):
LRIG3 (leucine rich repeats and immunoglobulin like domains 3)
HGNC
EggNOG, Ensembl, Inparanoid, NCBI, OMA, OrthoDB, Panther, Treefam
Chlorocebus sabaeus (green monkey):
LRIG3 (leucine rich repeats and immunoglobulin like domains 3)
NCBI
Ortholog
Heterocephalus glaber (naked mole-rat):
Lrig3 (leucine rich repeats and immunoglobulin like domains 3)
NCBI
Ortholog
Other homologs 2
Mus musculus (house mouse):
Lrig1 (leucine-rich repeats and immunoglobulin-like domains 1)
HGNC
OrthoMCL
Mus musculus (house mouse):
Lrig2 (leucine-rich repeats and immunoglobulin-like domains 2)
HGNC
OrthoMCL
Alliance orthologs 3
Mus musculus (house mouse):
Lrig3 (leucine-rich repeats and immunoglobulin-like domains 3)
Alliance
DIOPT (Ensembl Compara|HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PhylomeDB|SonicParanoid)
Rattus norvegicus (Norway rat):
Lrig3 (leucine-rich repeats and immunoglobulin-like domains 3)
Alliance
DIOPT (Ensembl Compara|HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PhylomeDB|SonicParanoid)
Danio rerio (zebrafish):
lrig3 (leucine-rich repeats and immunoglobulin-like domains 3)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid|ZFIN)
Caenorhabditis elegans (roundworm):
sma-10
Alliance
DIOPT (Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PhylomeDB|SonicParanoid)
Drosophila melanogaster (fruit fly):
lbk
Alliance
DIOPT (Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Xenopus laevis (African clawed frog):
lrig3.S
Alliance
DIOPT (Xenbase)
Xenopus tropicalis (tropical clawed frog):
lrig3
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Xenopus tropicalis (tropical clawed frog):
slc35g1
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Xenopus laevis (African clawed frog):
lrig3.L
Alliance
DIOPT (Xenbase)
Allele / Splice:
See ClinVar data
Latest Assembly:
GRCh38 - Human Genome Assembly GRCh38
Position:
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 12 58,872,155 - 58,920,504 (-) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 12 58,872,149 - 58,920,504 (-) Ensembl GRCh38 hg38 GRCh38 GRCh37 12 59,265,937 - 59,314,285 (-) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 12 57,552,204 - 57,600,529 (-) NCBI NCBI36 Build 36 hg18 NCBI36 Build 34 12 57,552,204 - 57,600,529 NCBI Celera 12 58,927,578 - 58,975,904 (-) NCBI Celera Cytogenetic Map 12 q14.1 NCBI HuRef 12 56,314,531 - 56,362,936 (-) NCBI HuRef CHM1_1 12 59,233,510 - 59,281,893 (-) NCBI CHM1_1 T2T-CHM13v2.0 12 58,852,431 - 58,900,780 (-) NCBI T2T-CHM13v2.0
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
LRIG3 Human (+)-schisandrin B multiple interactions ISO Lrig3 (Rattus norvegicus) 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of LRIG3 mRNA] CTD PMID:31150632 LRIG3 Human 1,2-dimethylhydrazine decreases expression ISO Lrig3 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of LRIG3 mRNA CTD PMID:22206623 LRIG3 Human 1,2-dimethylhydrazine multiple interactions ISO Lrig3 (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of LRIG3 mRNA CTD PMID:22206623 LRIG3 Human 17beta-estradiol multiple interactions ISO Lrig3 (Rattus norvegicus) 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of LRIG3 mRNA CTD PMID:26496021 LRIG3 Human 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Lrig3 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of LRIG3 mRNA CTD PMID:21570461 LRIG3 Human 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Lrig3 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in increased expression of LRIG3 mRNA CTD PMID:33387578 LRIG3 Human 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of LRIG3 mRNA CTD PMID:23152189 LRIG3 Human acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of LRIG3 mRNA CTD PMID:32763439 LRIG3 Human aflatoxin B1 increases expression ISO Lrig3 (Mus musculus) 6480464 Aflatoxin B1 results in increased expression of LRIG3 mRNA CTD PMID:19770486 LRIG3 Human aflatoxin B1 decreases methylation EXP 6480464 Aflatoxin B1 results in decreased methylation of LRIG3 gene CTD PMID:27153756 LRIG3 Human all-trans-retinoic acid multiple interactions ISO Lrig3 (Mus musculus) 6480464 [bisphenol F co-treated with Tretinoin] results in decreased expression of LRIG3 mRNA CTD PMID:30951980 LRIG3 Human aristolochic acid A decreases expression EXP 6480464 aristolochic acid I results in decreased expression of LRIG3 mRNA CTD PMID:33212167 LRIG3 Human arsane multiple interactions EXP 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of LRIG3 mRNA and [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of LRIG3 mRNA CTD PMID:39836092 LRIG3 Human arsenic atom multiple interactions EXP 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of LRIG3 mRNA and [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of LRIG3 mRNA CTD PMID:39836092 LRIG3 Human benzo[a]pyrene increases expression ISO Lrig3 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of LRIG3 mRNA CTD PMID:19770486 LRIG3 Human benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of LRIG3 mRNA CTD PMID:21632981 LRIG3 Human benzo[b]fluoranthene decreases expression ISO Lrig3 (Mus musculus) 6480464 benzo(b)fluoranthene results in decreased expression of LRIG3 mRNA CTD PMID:26377693 LRIG3 Human bis(2-ethylhexyl) phthalate decreases expression ISO Lrig3 (Mus musculus) 6480464 Diethylhexyl Phthalate results in decreased expression of LRIG3 mRNA CTD PMID:34319233 LRIG3 Human bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of LRIG3 mRNA CTD PMID:25047013 LRIG3 Human bisphenol A decreases methylation ISO Lrig3 (Mus musculus) 6480464 bisphenol A results in decreased methylation of LRIG3 promoter CTD PMID:27312807 LRIG3 Human bisphenol A increases expression ISO Lrig3 (Rattus norvegicus) 6480464 bisphenol A results in increased expression of LRIG3 mRNA CTD PMID:30816183 LRIG3 Human bisphenol A decreases expression ISO Lrig3 (Rattus norvegicus) 6480464 bisphenol A results in decreased expression of LRIG3 mRNA CTD PMID:25181051 LRIG3 Human bisphenol A multiple interactions ISO Lrig3 (Rattus norvegicus) 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of LRIG3 mRNA CTD PMID:26496021 LRIG3 Human bisphenol F multiple interactions ISO Lrig3 (Mus musculus) 6480464 [bisphenol F co-treated with Tretinoin] results in decreased expression of LRIG3 mRNA CTD PMID:30951980 LRIG3 Human cadmium dichloride increases expression ISO Lrig3 (Rattus norvegicus) 6480464 Cadmium Chloride results in increased expression of LRIG3 mRNA CTD PMID:33453195 LRIG3 Human cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of LRIG3 mRNA CTD PMID:38568856 LRIG3 Human calcitriol decreases expression EXP 6480464 Calcitriol results in decreased expression of LRIG3 mRNA CTD PMID:16002434 LRIG3 Human carbon nanotube decreases expression ISO Lrig3 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 LRIG3 Human chromium(6+) multiple interactions EXP 6480464 [zinc chromate results in increased abundance of chromium hexavalent ion] which results in increased expression of LRIG3 mRNA CTD PMID:38479592 LRIG3 Human clofibrate decreases expression ISO Lrig3 (Mus musculus) 6480464 Clofibrate results in decreased expression of LRIG3 mRNA CTD PMID:23811191 LRIG3 Human cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of LRIG3 mRNA CTD PMID:19320972 LRIG3 Human cobalt dichloride increases expression ISO Lrig3 (Rattus norvegicus) 6480464 cobaltous chloride results in increased expression of LRIG3 mRNA CTD PMID:24386269 LRIG3 Human copper atom multiple interactions EXP 6480464 [NSC 689534 binds to Copper] which results in decreased expression of LRIG3 mRNA CTD PMID:20971185 LRIG3 Human copper(0) multiple interactions EXP 6480464 [NSC 689534 binds to Copper] which results in decreased expression of LRIG3 mRNA CTD PMID:20971185 LRIG3 Human copper(II) sulfate decreases expression EXP 6480464 Copper Sulfate results in decreased expression of LRIG3 mRNA CTD PMID:19549813 LRIG3 Human cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of LRIG3 mRNA CTD PMID:27989131 LRIG3 Human decabromodiphenyl ether increases expression ISO Lrig3 (Rattus norvegicus) 6480464 decabromobiphenyl ether results in increased expression of LRIG3 mRNA CTD PMID:23914054 LRIG3 Human diethyl maleate decreases expression ISO Lrig3 (Rattus norvegicus) 6480464 diethyl maleate results in decreased expression of LRIG3 mRNA CTD PMID:21161181 LRIG3 Human dorsomorphin multiple interactions EXP 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 LRIG3 Human doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of LRIG3 mRNA CTD PMID:29803840 LRIG3 Human folic acid multiple interactions ISO Lrig3 (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of LRIG3 mRNA CTD PMID:22206623 LRIG3 Human fonofos increases methylation EXP 6480464 Fonofos results in increased methylation of LRIG3 promoter CTD PMID:22847954 LRIG3 Human formaldehyde decreases expression EXP 6480464 Formaldehyde results in decreased expression of LRIG3 mRNA CTD PMID:20655997 LRIG3 Human gentamycin increases expression ISO Lrig3 (Rattus norvegicus) 6480464 Gentamicins results in increased expression of LRIG3 mRNA CTD PMID:33387578 LRIG3 Human lead(0) affects expression EXP 6480464 Lead affects the expression of LRIG3 mRNA CTD PMID:28903495 LRIG3 Human leflunomide increases expression EXP 6480464 leflunomide results in increased expression of LRIG3 mRNA CTD PMID:28988120 LRIG3 Human lipopolysaccharide multiple interactions EXP 6480464 [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LRIG3 mRNA CTD PMID:35811015 LRIG3 Human manganese atom multiple interactions EXP 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of LRIG3 mRNA CTD PMID:39836092 LRIG3 Human manganese(0) multiple interactions EXP 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of LRIG3 mRNA CTD PMID:39836092 LRIG3 Human manganese(II) chloride multiple interactions EXP 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of LRIG3 mRNA CTD PMID:39836092 LRIG3 Human melphalan decreases expression EXP 6480464 Melphalan results in decreased expression of LRIG3 mRNA CTD PMID:22363485 LRIG3 Human methamphetamine increases expression ISO Lrig3 (Rattus norvegicus) 6480464 Methamphetamine results in increased expression of LRIG3 mRNA CTD PMID:19564919 LRIG3 Human nickel sulfate increases expression EXP 6480464 nickel sulfate results in increased expression of LRIG3 mRNA CTD PMID:22714537 LRIG3 Human oxaliplatin multiple interactions ISO Lrig3 (Rattus norvegicus) 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of LRIG3 mRNA CTD PMID:25729387 LRIG3 Human paracetamol affects expression ISO Lrig3 (Mus musculus) 6480464 Acetaminophen affects the expression of LRIG3 mRNA CTD PMID:17562736 LRIG3 Human paracetamol increases expression ISO Lrig3 (Rattus norvegicus) 6480464 Acetaminophen results in increased expression of LRIG3 mRNA CTD PMID:33387578 LRIG3 Human paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of LRIG3 mRNA CTD PMID:29067470 LRIG3 Human parathion increases methylation EXP 6480464 Parathion results in increased methylation of LRIG3 promoter CTD PMID:22847954 LRIG3 Human pirinixic acid decreases expression ISO Lrig3 (Mus musculus) 6480464 pirinixic acid results in decreased expression of LRIG3 mRNA CTD PMID:23811191 LRIG3 Human potassium chromate decreases expression EXP 6480464 potassium chromate(VI) results in decreased expression of LRIG3 mRNA CTD PMID:22714537 LRIG3 Human quercetin decreases expression EXP 6480464 Quercetin results in decreased expression of LRIG3 mRNA CTD PMID:21632981 LRIG3 Human resorcinol decreases expression EXP 6480464 resorcinol results in decreased expression of LRIG3 mRNA CTD PMID:22623647 LRIG3 Human S-(1,2-dichlorovinyl)-L-cysteine multiple interactions EXP 6480464 [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LRIG3 mRNA CTD PMID:35811015 LRIG3 Human SB 431542 multiple interactions EXP 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 LRIG3 Human sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of LRIG3 mRNA CTD PMID:38568856 LRIG3 Human sodium arsenite multiple interactions EXP 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of LRIG3 mRNA and [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of LRIG3 mRNA CTD PMID:39836092 LRIG3 Human terbufos increases methylation EXP 6480464 terbufos results in increased methylation of LRIG3 promoter CTD PMID:22847954 LRIG3 Human testosterone increases expression ISO Lrig3 (Mus musculus) 6480464 Testosterone deficiency results in increased expression of LRIG3 mRNA CTD PMID:33848595 LRIG3 Human tetrachloromethane multiple interactions ISO Lrig3 (Rattus norvegicus) 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of LRIG3 mRNA] CTD PMID:31150632 LRIG3 Human tetrachloromethane decreases expression ISO Lrig3 (Rattus norvegicus) 6480464 Carbon Tetrachloride results in decreased expression of LRIG3 mRNA CTD PMID:30723492 and PMID:31150632 LRIG3 Human tetracycline increases expression ISO Lrig3 (Mus musculus) 6480464 Tetracycline results in increased expression of LRIG3 mRNA CTD PMID:16917069 LRIG3 Human thioacetamide increases expression ISO Lrig3 (Rattus norvegicus) 6480464 Thioacetamide results in increased expression of LRIG3 mRNA CTD PMID:34492290 LRIG3 Human thiram decreases expression EXP 6480464 Thiram results in decreased expression of LRIG3 mRNA CTD PMID:38568856 LRIG3 Human titanium dioxide decreases methylation ISO Lrig3 (Mus musculus) 6480464 titanium dioxide results in decreased methylation of LRIG3 gene CTD PMID:35295148 LRIG3 Human topotecan multiple interactions ISO Lrig3 (Rattus norvegicus) 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of LRIG3 mRNA CTD PMID:25729387 LRIG3 Human toxaphene increases expression ISO Lrig3 (Rattus norvegicus) 6480464 Toxaphene results in increased expression of LRIG3 mRNA CTD PMID:23153324 LRIG3 Human trichloroethene increases expression ISO Lrig3 (Rattus norvegicus) 6480464 Trichloroethylene results in increased expression of LRIG3 mRNA CTD PMID:33387578 LRIG3 Human trichostatin A decreases expression EXP 6480464 trichostatin A results in decreased expression of LRIG3 mRNA CTD PMID:24935251 and PMID:26272509 LRIG3 Human trichostatin A multiple interactions EXP 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LRIG3 mRNA CTD PMID:27188386 LRIG3 Human trimellitic anhydride decreases expression ISO Lrig3 (Mus musculus) 6480464 trimellitic anhydride results in decreased expression of LRIG3 mRNA CTD PMID:19042947 LRIG3 Human valproic acid decreases methylation EXP 6480464 Valproic Acid results in decreased methylation of LRIG3 gene CTD PMID:29154799 LRIG3 Human valproic acid increases expression ISO Lrig3 (Mus musculus) 6480464 Valproic Acid results in increased expression of LRIG3 mRNA CTD PMID:24896083 LRIG3 Human valproic acid multiple interactions EXP 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LRIG3 mRNA CTD PMID:27188386 LRIG3 Human valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of LRIG3 mRNA CTD PMID:23179753 more ...
(+)-schisandrin B (ISO) 1,2-dimethylhydrazine (ISO) 17beta-estradiol (ISO) 2,3,7,8-tetrachlorodibenzodioxine (EXP,ISO) acrylamide (EXP) aflatoxin B1 (EXP,ISO) all-trans-retinoic acid (ISO) aristolochic acid A (EXP) arsane (EXP) arsenic atom (EXP) benzo[a]pyrene (EXP,ISO) benzo[b]fluoranthene (ISO) bis(2-ethylhexyl) phthalate (ISO) bisphenol A (EXP,ISO) bisphenol F (ISO) cadmium dichloride (EXP,ISO) calcitriol (EXP) carbon nanotube (ISO) chromium(6+) (EXP) clofibrate (ISO) cobalt dichloride (EXP,ISO) copper atom (EXP) copper(0) (EXP) copper(II) sulfate (EXP) cyclosporin A (EXP) decabromodiphenyl ether (ISO) diethyl maleate (ISO) dorsomorphin (EXP) doxorubicin (EXP) folic acid (ISO) fonofos (EXP) formaldehyde (EXP) gentamycin (ISO) lead(0) (EXP) leflunomide (EXP) lipopolysaccharide (EXP) manganese atom (EXP) manganese(0) (EXP) manganese(II) chloride (EXP) melphalan (EXP) methamphetamine (ISO) nickel sulfate (EXP) oxaliplatin (ISO) paracetamol (EXP,ISO) parathion (EXP) pirinixic acid (ISO) potassium chromate (EXP) quercetin (EXP) resorcinol (EXP) S-(1,2-dichlorovinyl)-L-cysteine (EXP) SB 431542 (EXP) sodium arsenite (EXP) terbufos (EXP) testosterone (ISO) tetrachloromethane (ISO) tetracycline (ISO) thioacetamide (ISO) thiram (EXP) titanium dioxide (ISO) topotecan (ISO) toxaphene (ISO) trichloroethene (ISO) trichostatin A (EXP) trimellitic anhydride (ISO) valproic acid (EXP,ISO)
LRIG3 (Homo sapiens - human)
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 12 58,872,155 - 58,920,504 (-) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 12 58,872,149 - 58,920,504 (-) Ensembl GRCh38 hg38 GRCh38 GRCh37 12 59,265,937 - 59,314,285 (-) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 12 57,552,204 - 57,600,529 (-) NCBI NCBI36 Build 36 hg18 NCBI36 Build 34 12 57,552,204 - 57,600,529 NCBI Celera 12 58,927,578 - 58,975,904 (-) NCBI Celera Cytogenetic Map 12 q14.1 NCBI HuRef 12 56,314,531 - 56,362,936 (-) NCBI HuRef CHM1_1 12 59,233,510 - 59,281,893 (-) NCBI CHM1_1 T2T-CHM13v2.0 12 58,852,431 - 58,900,780 (-) NCBI T2T-CHM13v2.0
Lrig3 (Mus musculus - house mouse)
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 10 125,802,088 - 125,851,228 (+) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 10 125,802,037 - 125,851,228 (+) Ensembl GRCm39 Ensembl GRCm38 10 125,966,219 - 126,015,359 (+) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 10 125,966,168 - 126,015,359 (+) Ensembl GRCm38 mm10 GRCm38 MGSCv37 10 125,403,275 - 125,452,415 (+) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 10 125,369,225 - 125,418,184 (+) NCBI MGSCv36 mm8 Celera 10 128,374,213 - 128,423,610 (+) NCBI Celera Cytogenetic Map 10 D3 NCBI cM Map 10 73.66 NCBI
Lrig3 (Rattus norvegicus - Norway rat)
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 7 63,701,724 - 63,751,898 (+) NCBI GRCr8 mRatBN7.2 7 61,816,313 - 61,866,275 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 7 61,816,342 - 61,866,481 (+) Ensembl mRatBN7.2 Ensembl Rnor_6.0 7 69,213,098 - 69,263,251 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 7 69,213,147 - 69,263,142 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 7 69,404,280 - 69,454,372 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 7 66,012,273 - 66,062,608 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 Celera 7 58,970,827 - 59,020,519 (+) NCBI Celera Cytogenetic Map 7 q22 NCBI
Lrig3 (Chinchilla lanigera - long-tailed chinchilla)
Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955458 6,562,167 - 6,601,517 (-) Ensembl ChiLan1.0 ChiLan1.0 NW_004955458 6,562,167 - 6,601,517 (-) NCBI ChiLan1.0 ChiLan1.0
LRIG3 (Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 10 35,419,946 - 35,468,463 (+) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 12 35,416,855 - 35,465,234 (+) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 12 30,012,251 - 30,060,570 (+) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 12 30,275,789 - 30,323,781 (+) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 12 30,275,498 - 30,323,358 (+) Ensembl panpan1.1 panPan2
LRIG3 (Canis lupus familiaris - dog)
Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 10 2,723,836 - 2,772,630 (-) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 10 2,724,951 - 2,772,636 (-) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 10 2,789,369 - 2,838,992 (-) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 10 2,737,466 - 2,787,369 (-) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 10 2,739,331 - 2,787,479 (-) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 10 2,714,388 - 2,764,026 (-) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 10 2,956,608 - 3,006,074 (-) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 10 3,082,721 - 3,131,801 (-) NCBI UU_Cfam_GSD_1.0
Lrig3 (Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl HiC_Itri_2 NW_024404945 55,940,378 - 55,981,106 (+) NCBI HiC_Itri_2 SpeTri2.0 Ensembl NW_004936646 2,886,069 - 2,929,552 (-) Ensembl SpeTri2.0 SpeTri2.0 Ensembl SpeTri2.0 NW_004936646 2,889,331 - 2,929,836 (-) NCBI SpeTri2.0 SpeTri2.0 SpeTri2.0
LRIG3 (Sus scrofa - pig)
Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 5 24,066,623 - 24,117,970 (-) Ensembl Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa11.1 5 24,066,611 - 24,117,971 (-) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 5 25,903,031 - 25,952,707 (-) NCBI Sscrofa10.2 Sscrofa10.2 susScr3
LRIG3 (Chlorocebus sabaeus - green monkey)
Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 11 54,806,138 - 54,853,811 (-) NCBI ChlSab1.1 ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 11 54,806,579 - 54,853,645 (-) Ensembl ChlSab1.1 ChlSab1.1 Ensembl chlSab2 Vero_WHO_p1.0 NW_023666037 191,070,125 - 191,117,716 (+) NCBI Vero_WHO_p1.0 Vero_WHO_p1.0
Lrig3 (Heterocephalus glaber - naked mole-rat)
.
Predicted Target Of
Count of predictions: 2182 Count of miRNA genes: 892 Interacting mature miRNAs: 1061 Transcripts: ENST00000320743, ENST00000379141, ENST00000433272, ENST00000547329, ENST00000548968, ENST00000550304, ENST00000550825, ENST00000552267, ENST00000552646 Prediction methods: Microtar, Miranda, Rnahybrid, Targetscan Result types: miRGate_prediction
597176141 GWAS1272215_H leucine-rich repeats and immunoglobulin-like domains protein 3 measurement QTL GWAS1272215 (human) 2e-42 leucine-rich repeats and immunoglobulin-like domains protein 3 measurement 12 58879191 58879192 Human 597267295 GWAS1363369_H leucine-rich repeats and immunoglobulin-like domains protein 3 measurement QTL GWAS1363369 (human) 9e-50 leucine-rich repeats and immunoglobulin-like domains protein 3 measurement 12 58890047 58890048 Human 597315036 GWAS1411110_H cognitive function measurement QTL GWAS1411110 (human) 0.00001 cognitive behavior trait (VT:0010450) 12 58904296 58904297 Human 597126560 GWAS1222634_H total hip arthroplasty, osteoarthritis QTL GWAS1222634 (human) 7e-13 total hip arthroplasty, osteoarthritis 12 58895568 58895569 Human 597297984 GWAS1394058_H leucine-rich repeats and immunoglobulin-like domains protein 3 measurement QTL GWAS1394058 (human) 5e-14 leucine-rich repeats and immunoglobulin-like domains protein 3 measurement 12 58879191 58879192 Human 597113181 GWAS1209255_H osteoarthritis, hip QTL GWAS1209255 (human) 1e-09 osteoarthritis, hip 12 58895817 58895818 Human 597512758 GWAS1608832_H anthropometric measurement QTL GWAS1608832 (human) 6e-09 anthropometric measurement body morphological measurement (CMO:0000021) 12 58913844 58913845 Human 597304484 GWAS1400558_H leucine-rich repeats and immunoglobulin-like domains protein 3 measurement QTL GWAS1400558 (human) 9e-20 leucine-rich repeats and immunoglobulin-like domains protein 3 measurement 12 58890047 58890048 Human
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
entire extraembryonic component
1204
2436
2788
2232
4967
1723
2345
3
624
1676
465
2270
7042
6211
51
3727
1
851
1742
1610
175
1
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENST00000320743 ⟹ ENSP00000326759
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38.p14 Ensembl 12 58,872,155 - 58,920,504 (-) Ensembl
Ensembl Acc Id:
ENST00000379141 ⟹ ENSP00000368436
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38.p14 Ensembl 12 58,872,149 - 58,919,546 (-) Ensembl
Ensembl Acc Id:
ENST00000433272 ⟹ ENSP00000413143
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38.p14 Ensembl 12 58,872,548 - 58,920,434 (-) Ensembl
Ensembl Acc Id:
ENST00000547329
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38.p14 Ensembl 12 58,880,360 - 58,882,886 (-) Ensembl
Ensembl Acc Id:
ENST00000548968
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38.p14 Ensembl 12 58,913,495 - 58,920,156 (-) Ensembl
Ensembl Acc Id:
ENST00000550304
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38.p14 Ensembl 12 58,885,880 - 58,887,035 (-) Ensembl
Ensembl Acc Id:
ENST00000550825 ⟹ ENSP00000449169
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38.p14 Ensembl 12 58,873,551 - 58,874,572 (-) Ensembl
Ensembl Acc Id:
ENST00000552267 ⟹ ENSP00000449109
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38.p14 Ensembl 12 58,888,874 - 58,914,583 (-) Ensembl
Ensembl Acc Id:
ENST00000552646
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38.p14 Ensembl 12 58,874,053 - 58,877,494 (-) Ensembl
RefSeq Acc Id:
NM_001136051 ⟹ NP_001129523
RefSeq Status:
VALIDATED
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38 12 58,872,155 - 58,919,505 (-) NCBI GRCh37 12 59,265,937 - 59,314,319 (-) NCBI HuRef 12 56,314,531 - 56,362,936 (-) NCBI CHM1_1 12 59,233,510 - 59,280,901 (-) NCBI T2T-CHM13v2.0 12 58,852,431 - 58,899,781 (-) NCBI
Sequence:
AGAATTCGGTCATTCTCCAAGTTATGGTGGACGTACTTCTGTTGTTCTCCCTCTGCTTGCTTTTTCACATTAGCAGACCGGACTTAAGTCACAACAGATTATCTTTCATCAAGGCAAGTTCCATGAGC CACCTTCAAAGCCTTCGAGAAGTGAAACTGAACAACAATGAATTGGAGACCATTCCAAATCTGGGACCAGTCTCGGCAAATATTACACTTCTCTCCTTGGCTGGAAACAGGATTGTTGAAATACTCCC TGAACATCTGAAAGAGTTTCAGTCCCTTGAAACTTTGGACCTTAGCAGCAACAATATTTCAGAGCTCCAAACTGCATTTCCAGCCCTACAGCTCAAATATCTGTATCTCAACAGCAACCGAGTCACAT CAATGGAACCTGGGTATTTTGACAATTTGGCCAACACACTCCTTGTGTTAAAGCTGAACAGGAACCGAATCTCAGCTATCCCACCCAAGATGTTTAAACTGCCCCAACTGCAACATCTCGAATTGAAC CGAAACAAGATTAAAAATGTAGATGGACTGACATTCCAAGGCCTTGGTGCTCTGAAGTCTCTGAAAATGCAAAGAAATGGAGTAACGAAACTTATGGATGGAGCTTTTTGGGGGCTGAGCAACATGGA AATTTTGCAGCTGGACCATAACAACCTAACAGAGATTACCAAAGGCTGGCTTTACGGCTTGCTGATGCTGCAGGAACTTCATCTCAGCCAAAATGCCATCAACAGGATCAGCCCTGATGCCTGGGAGT TCTGCCAGAAGCTCAGTGAGCTGGACCTAACTTTCAATCACTTATCAAGGTTAGATGATTCAAGCTTCCTTGGCCTAAGCTTACTAAATACACTGCACATTGGGAACAACAGAGTCAGCTACATTGCT GATTGTGCCTTCCGGGGGCTTTCCAGTTTAAAGACTTTGGATCTGAAGAACAATGAAATTTCCTGGACTATTGAAGACATGAATGGTGCTTTCTCTGGGCTTGACAAACTGAGGCGACTGATACTCCA AGGAAATCGGATCCGTTCTATTACTAAAAAAGCCTTCACTGGTTTGGATGCATTGGAGCATCTAGACCTGAGTGACAACGCAATCATGTCTTTACAAGGCAATGCATTTTCACAAATGAAGAAACTGC AACAATTGCATTTAAATACATCAAGCCTTTTGTGCGATTGCCAGCTAAAATGGCTCCCACAGTGGGTGGCGGAAAACAACTTTCAGAGCTTTGTAAATGCCAGTTGTGCCCATCCTCAGCTGCTAAAA GGAAGAAGCATTTTTGCTGTTAGCCCAGATGGCTTTGTGTGTGATGATTTTCCCAAACCCCAGATCACGGTTCAGCCAGAAACACAGTCGGCAATAAAAGGTTCCAATTTGAGTTTCATCTGCTCAGC TGCCAGCAGCAGTGATTCCCCAATGACTTTTGCTTGGAAAAAAGACAATGAACTACTGCATGATGCTGAAATGGAAAATTATGCACACCTCCGGGCCCAAGGTGGCGAGGTGATGGAGTATACCACCA TCCTTCGGCTGCGCGAGGTGGAATTTGCCAGTGAGGGGAAATATCAGTGTGTCATCTCCAATCACTTTGGTTCATCCTACTCTGTCAAAGCCAAGCTTACAGTAAATATGCTTCCCTCATTCACCAAG ACCCCCATGGATCTCACCATCCGAGCTGGGGCCATGGCACGCTTGGAGTGTGCTGCTGTGGGGCACCCAGCCCCCCAGATAGCCTGGCAGAAGGATGGGGGCACAGACTTCCCAGCTGCACGGGAGAG ACGCATGCATGTGATGCCCGAGGATGACGTGTTCTTTATCGTGGATGTGAAGATAGAGGACATTGGGGTATACAGCTGCACAGCTCAGAACAGTGCAGGAAGTATTTCAGCAAATGCAACTCTGACTG TCCTAGAAACACCATCATTTTTGCGGCCACTGTTGGACCGAACTGTAACCAAGGGAGAAACAGCCGTCCTACAGTGCATTGCTGGAGGAAGCCCTCCCCCTAAACTGAACTGGACCAAAGATGATAGC CCATTGGTGGTAACCGAGAGGCACTTTTTTGCAGCAGGCAATCAGCTTCTGATTATTGTGGACTCAGATGTCAGTGATGCTGGGAAATACACATGTGAGATGTCTAACACCCTTGGCACTGAGAGAGG AAACGTGCGCCTCAGTGTGATCCCCACTCCAACCTGCGACTCCCCTCAGATGACAGCCCCATCGTTAGACGATGACGGATGGGCCACTGTGGGTGTCGTGATCATAGCCGTGGTTTGCTGTGTGGTGG GCACGTCACTCGTGTGGGTGGTCATCATATACCACACAAGGCGGAGGAATGAAGATTGCAGCATTACCAACACAGATGAGACCAACTTGCCAGCAGATATTCCTAGTTATTTGTCATCTCAGGGAACG TTAGCTGACAGGCAGGATGGGTACGTGTCTTCAGAAAGTGGAAGCCACCACCAGTTTGTCACATCTTCAGGTGCTGGATTTTTCTTACCACAACATGACAGTAGTGGGACCTGCCATATTGACAATAG CAGTGAAGCTGATGTGGAAGCTGCCACAGATCTGTTCCTTTGTCCGTTTTTGGGATCCACAGGCCCTATGTATTTGAAGGGAAATGTGTATGGCTCAGATCCTTTTGAAACATATCATACAGGTTGCA GTCCTGACCCAAGAACAGTTTTAATGGACCACTATGAGCCCAGTTACATAAAGAAAAAGGAGTGCTACCCATGTTCTCATCCTTCAGAAGAATCCTGCGAACGGAGCTTCAGTAATATATCGTGGCCT TCACATGTGAGGAAGCTACTTAACACTAGTTACTCTCACAATGAAGGACCTGGAATGAAAAATCTGTGTCTAAACAAGTCCTCTTTAGATTTTAGTGCAAATCCAGAGCCAGCGTCGGTTGCCTCGAG TAATTCTTTCATGGGTACCTTTGGAAAAGCTCTCAGGAGACCTCACCTAGATGCCTATTCAAGCTTTGGACAGCCATCAGATTGTCAGCCAAGAGCCTTTTATTTGAAAGCTCATTCTTCCCCAGACT TGGACTCTGGGTCAGAGGAAGATGGGAAAGAAAGGACAGATTTTCAGGAAGAAAATCACATTTGTACCTTTAAACAGACTTTAGAAAACTACAGGACTCCAAATTTTCAGTCTTATGACTTGGACACA TAGACTGAATGAGACCAAAGGAAAAGCTTAACATACTACCTCAAGTGAACTTTTATTTAAAAGAGAGAGAATCTTATGTTTTTTAAATGGAGTTATGAATTTTAAAAGGATAAAAATGCTTTATTTAT ACAGATGAACCAAAATTACAAAAAGTTATGAAAATTTTTATACTGGGAATGATGCTCATATAAGAATACCTTTTTAAACTATTTTTTAACTTTGTTTTATGCAAAAAAGTATCTTACGTAAATTAATG ATATAAATCATGATTATTTTATGTATTTTTATAATGCCAGATTTCTTTTTATGGAAAATGAGTTACTAAAGCATTTTAAATAATACCTGCCTTGTACCATTTTTTAAATAGAAGTTACTTCATTATAT TTTGCACATTATATTTAATAAAATGTGTCAATTTGA
hide sequence
RefSeq Acc Id:
NM_153377 ⟹ NP_700356
RefSeq Status:
VALIDATED
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38 12 58,872,155 - 58,920,504 (-) NCBI GRCh37 12 59,265,937 - 59,314,319 (-) NCBI Build 36 12 57,552,204 - 57,600,529 (-) NCBI Archive HuRef 12 56,314,531 - 56,362,936 (-) NCBI CHM1_1 12 59,233,510 - 59,281,893 (-) NCBI T2T-CHM13v2.0 12 58,852,431 - 58,900,780 (-) NCBI
Sequence:
GCAGACAAGAAGGGGCTTCGGCGAGCCGACGCTGCTCAAGCTGCAACTCTGTTGCAGTTGGCAG TTCTTTTCGGTTTCCCTCCTGCTGTTTGGGGGCATGAAAGGGCTTCGCCGCCGGGAGTAAAAGAAGGAATTGACCGGGCAGCGCGAGGGAGGAGCGCGCACGCGACCGCGAGGGCGGGCGTGCACCCT CGGCTGGAAGTTTGTGCCGGGCCCCGAGCGCGCGCCGGCTGGGAGCTTCGGGTAGAGACCTAGGCCGCTGGACCGCGATGAGCGCGCCGAGCCTCCGTGCGCGCGCCGCGGGGTTGGGGCTGCTGCTG TGCGCGGTGCTGGGGCGCGCTGGCCGGTCAGACAGCGGCGGTCGCGGGGAACTCGGGCAGCCCTCTGGGGTAGCCGCCGAGCGCCCATGCCCCACTACCTGCCGCTGCCTCGGGGACCTGCTGGACTG CAGTCGTAAGCGGCTAGCGCGTCTTCCCGAGCCACTCCCGTCCTGGGTCGCTCGGCTGGACTTAAGTCACAACAGATTATCTTTCATCAAGGCAAGTTCCATGAGCCACCTTCAAAGCCTTCGAGAAG TGAAACTGAACAACAATGAATTGGAGACCATTCCAAATCTGGGACCAGTCTCGGCAAATATTACACTTCTCTCCTTGGCTGGAAACAGGATTGTTGAAATACTCCCTGAACATCTGAAAGAGTTTCAG TCCCTTGAAACTTTGGACCTTAGCAGCAACAATATTTCAGAGCTCCAAACTGCATTTCCAGCCCTACAGCTCAAATATCTGTATCTCAACAGCAACCGAGTCACATCAATGGAACCTGGGTATTTTGA CAATTTGGCCAACACACTCCTTGTGTTAAAGCTGAACAGGAACCGAATCTCAGCTATCCCACCCAAGATGTTTAAACTGCCCCAACTGCAACATCTCGAATTGAACCGAAACAAGATTAAAAATGTAG ATGGACTGACATTCCAAGGCCTTGGTGCTCTGAAGTCTCTGAAAATGCAAAGAAATGGAGTAACGAAACTTATGGATGGAGCTTTTTGGGGGCTGAGCAACATGGAAATTTTGCAGCTGGACCATAAC AACCTAACAGAGATTACCAAAGGCTGGCTTTACGGCTTGCTGATGCTGCAGGAACTTCATCTCAGCCAAAATGCCATCAACAGGATCAGCCCTGATGCCTGGGAGTTCTGCCAGAAGCTCAGTGAGCT GGACCTAACTTTCAATCACTTATCAAGGTTAGATGATTCAAGCTTCCTTGGCCTAAGCTTACTAAATACACTGCACATTGGGAACAACAGAGTCAGCTACATTGCTGATTGTGCCTTCCGGGGGCTTT CCAGTTTAAAGACTTTGGATCTGAAGAACAATGAAATTTCCTGGACTATTGAAGACATGAATGGTGCTTTCTCTGGGCTTGACAAACTGAGGCGACTGATACTCCAAGGAAATCGGATCCGTTCTATT ACTAAAAAAGCCTTCACTGGTTTGGATGCATTGGAGCATCTAGACCTGAGTGACAACGCAATCATGTCTTTACAAGGCAATGCATTTTCACAAATGAAGAAACTGCAACAATTGCATTTAAATACATC AAGCCTTTTGTGCGATTGCCAGCTAAAATGGCTCCCACAGTGGGTGGCGGAAAACAACTTTCAGAGCTTTGTAAATGCCAGTTGTGCCCATCCTCAGCTGCTAAAAGGAAGAAGCATTTTTGCTGTTA GCCCAGATGGCTTTGTGTGTGATGATTTTCCCAAACCCCAGATCACGGTTCAGCCAGAAACACAGTCGGCAATAAAAGGTTCCAATTTGAGTTTCATCTGCTCAGCTGCCAGCAGCAGTGATTCCCCA ATGACTTTTGCTTGGAAAAAAGACAATGAACTACTGCATGATGCTGAAATGGAAAATTATGCACACCTCCGGGCCCAAGGTGGCGAGGTGATGGAGTATACCACCATCCTTCGGCTGCGCGAGGTGGA ATTTGCCAGTGAGGGGAAATATCAGTGTGTCATCTCCAATCACTTTGGTTCATCCTACTCTGTCAAAGCCAAGCTTACAGTAAATATGCTTCCCTCATTCACCAAGACCCCCATGGATCTCACCATCC GAGCTGGGGCCATGGCACGCTTGGAGTGTGCTGCTGTGGGGCACCCAGCCCCCCAGATAGCCTGGCAGAAGGATGGGGGCACAGACTTCCCAGCTGCACGGGAGAGACGCATGCATGTGATGCCCGAG GATGACGTGTTCTTTATCGTGGATGTGAAGATAGAGGACATTGGGGTATACAGCTGCACAGCTCAGAACAGTGCAGGAAGTATTTCAGCAAATGCAACTCTGACTGTCCTAGAAACACCATCATTTTT GCGGCCACTGTTGGACCGAACTGTAACCAAGGGAGAAACAGCCGTCCTACAGTGCATTGCTGGAGGAAGCCCTCCCCCTAAACTGAACTGGACCAAAGATGATAGCCCATTGGTGGTAACCGAGAGGC ACTTTTTTGCAGCAGGCAATCAGCTTCTGATTATTGTGGACTCAGATGTCAGTGATGCTGGGAAATACACATGTGAGATGTCTAACACCCTTGGCACTGAGAGAGGAAACGTGCGCCTCAGTGTGATC CCCACTCCAACCTGCGACTCCCCTCAGATGACAGCCCCATCGTTAGACGATGACGGATGGGCCACTGTGGGTGTCGTGATCATAGCCGTGGTTTGCTGTGTGGTGGGCACGTCACTCGTGTGGGTGGT CATCATATACCACACAAGGCGGAGGAATGAAGATTGCAGCATTACCAACACAGATGAGACCAACTTGCCAGCAGATATTCCTAGTTATTTGTCATCTCAGGGAACGTTAGCTGACAGGCAGGATGGGT ACGTGTCTTCAGAAAGTGGAAGCCACCACCAGTTTGTCACATCTTCAGGTGCTGGATTTTTCTTACCACAACATGACAGTAGTGGGACCTGCCATATTGACAATAGCAGTGAAGCTGATGTGGAAGCT GCCACAGATCTGTTCCTTTGTCCGTTTTTGGGATCCACAGGCCCTATGTATTTGAAGGGAAATGTGTATGGCTCAGATCCTTTTGAAACATATCATACAGGTTGCAGTCCTGACCCAAGAACAGTTTT AATGGACCACTATGAGCCCAGTTACATAAAGAAAAAGGAGTGCTACCCATGTTCTCATCCTTCAGAAGAATCCTGCGAACGGAGCTTCAGTAATATATCGTGGCCTTCACATGTGAGGAAGCTACTTA ACACTAGTTACTCTCACAATGAAGGACCTGGAATGAAAAATCTGTGTCTAAACAAGTCCTCTTTAGATTTTAGTGCAAATCCAGAGCCAGCGTCGGTTGCCTCGAGTAATTCTTTCATGGGTACCTTT GGAAAAGCTCTCAGGAGACCTCACCTAGATGCCTATTCAAGCTTTGGACAGCCATCAGATTGTCAGCCAAGAGCCTTTTATTTGAAAGCTCATTCTTCCCCAGACTTGGACTCTGGGTCAGAGGAAGA TGGGAAAGAAAGGACAGATTTTCAGGAAGAAAATCACATTTGTACCTTTAAACAGACTTTAGAAAACTACAGGACTCCAAATTTTCAGTCTTATGACTTGGACACATAGACTGAATGAGACCAAAGGA AAAGCTTAACATACTACCTCAAGTGAACTTTTATTTAAAAGAGAGAGAATCTTATGTTTTTTAAATGGAGTTATGAATTTTAAAAGGATAAAAATGCTTTATTTATACAGATGAACCAAAATTACAAA AAGTTATGAAAATTTTTATACTGGGAATGATGCTCATATAAGAATACCTTTTTAAACTATTTTTTAACTTTGTTTTATGCAAAAAAGTATCTTACGTAAATTAATGATATAAATCATGATTATTTTAT GTATTTTTATAATGCCAGATTTCTTTTTATGGAAAATGAGTTACTAAAGCATTTTAAATAATACCTGCCTTGTACCATTTTTTAAATAGAAGTTACTTCATTATATTTTGCACATTATATTTAATAAA ATGTGTCAATTTGA
hide sequence
RefSeq Acc Id:
XM_017018790 ⟹ XP_016874279
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38 12 58,880,273 - 58,920,504 (-) NCBI
Sequence:
GAAAAAGTTTCTTTTGCAGACAAGAAGGGGCTTCGGCGAGCCGACGCTGCTCAAGCTGCAACTC TGTTGCAGTTGGCAGTTCTTTTCGGTTTCCCTCCTGCTGTTTGGGGGCATGAAAGGGCTTCGCCGCCGGGAGTAAAAGAAGGAATTGACCGGGCAGCGCGAGGGAGGAGCGCGCACGCGACCGCGAGG GCGGGCGTGCACCCTCGGCTGGAAGTTTGTGCCGGGCCCCGAGCGCGCGCCGGCTGGGAGCTTCGGGTAGAGACCTAGGCCGCTGGACCGCGATGAGCGCGCCGAGCCTCCGTGCGCGCGCCGCGGGG TTGGGGCTGCTGCTGTGCGCGGTGCTGGGGCGCGCTGGCCGGTCAGACAGCGGCGGTCGCGGGGAACTCGGGCAGCCCTCTGGGGTAGCCGCCGAGCGCCCATGCCCCACTACCTGCCGCTGCCTCGG GGACCTGCTGGACTGCAGTCGTAAGCGGCTAGCGCGTCTTCCCGAGCCACTCCCGTCCTGGGTCGCTCGGCTGGACTTAAGTCACAACAGATTATCTTTCATCAAGGCAAGTTCCATGAGCCACCTTC AAAGCCTTCGAGAAGTGAAACTGAACAACAATGAATTGGAGACCATTCCAAATCTGGGACCAGTCTCGGCAAATATTACACTTCTCTCCTTGGCTGGAAACAGGATTGTTGAAATACTCCCTGAACAT CTGAAAGAGTTTCAGTCCCTTGAAACTTTGGACCTTAGCAGCAACAATATTTCAGAGCTCCAAACTGCATTTCCAGCCCTACAGCTCAAATATCTGTATCTCAACAGCAACCGAGTCACATCAATGGA ACCTGGGTATTTTGACAATTTGGCCAACACACTCCTTGTGTTAAAGCTGAACAGGAACCGAATCTCAGCTATCCCACCCAAGATGTTTAAACTGCCCCAACTGCAACATCTCGAATTGAACCGAAACA AGATTAAAAATGTAGATGGACTGACATTCCAAGGCCTTGGTGCTCTGAAGTCTCTGAAAATGCAAAGAAATGGAGTAACGAAACTTATGGATGGAGCTTTTTGGGGGCTGAGCAACATGGAAATTTTG CAGCTGGACCATAACAACCTAACAGAGATTACCAAAGGCTGGCTTTACGGCTTGCTGATGCTGCAGGAACTTCATCTCAGCCAAAATGCCATCAACAGGATCAGCCCTGATGCCTGGGAGTTCTGCCA GAAGCTCAGTGAGCTGGACCTAACTTTCAATCACTTATCAAGGTTAGATGATTCAAGCTTCCTTGGCCTAAGCTTACTAAATACACTGCACATTGGGAACAACAGAGTCAGCTACATTGCTGATTGTG CCTTCCGGGGGCTTTCCAGTTTAAAGACTTTGGATCTGAAGAACAATGAAATTTCCTGGACTATTGAAGACATGAATGGTGCTTTCTCTGGGCTTGACAAACTGAGGCGACTGATACTCCAAGGAAAT CGGATCCGTTCTATTACTAAAAAAGCCTTCACTGGTTTGGATGCATTGGAGCATCTAGACCTGAGTGACAACGCAATCATGTCTTTACAAGGCAATGCATTTTCACAAATGAAGAAACTGCAACAATT GCATTTAAATACATCAAGCCTTTTGTGCGATTGCCAGCTAAAATGGCTCCCACAGTGGGTGGCGGAAAACAACTTTCAGAGCTTTGTAAATGCCAGTTGTGCCCATCCTCAGCTGCTAAAAGGAAGAA GCATTTTTGCTGTTAGCCCAGATGGCTTTGTGTGTGATGATTTTCCCAAACCCCAGATCACGGTTCAGCCAGAAACACAGTCGGCAATAAAAGGTTCCAATTTGAGTTTCATCTGCTCAGCTGCCAGC AGCAGTGATTCCCCAATGACTTTTGCTTGGAAAAAAGACAATGAACTACTGCATGATGCTGAAATGGAAAATTATGCACACCTCCGGGCCCAAGGTGGCGAGGTGATGGAGTATACCACCATCCTTCG GCTGCGCGAGGTGGAATTTGCCAGTGAGGGGAAATATCAGTGTGTCATCTCCAATCACTTTGGTTCATCCTACTCTGTCAAAGCCAAGCTTACAGTAAATATTCCCCACCTGACTCTTCCTTTCCCTA CCTTTCATTCCACAAAATTAAGATTCTTGGTTATTTGTATCTAAACCTGCAATTATGTTGAAGACGACACCGTACTCAGTGTGGTGAGTAACACAGAGATGAACCAGACATGTTTTTGCTCTTTTTTT TTTCTTTTTCTTTTTTTTTTTTTTGAGACGGAATCTTGCACTGTCACCCA
hide sequence
RefSeq Acc Id:
XM_054371063 ⟹ XP_054227038
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source T2T-CHM13v2.0 12 58,860,549 - 58,900,780 (-) NCBI
RefSeq Acc Id:
NP_700356 ⟸ NM_153377
- Peptide Label:
isoform 2 precursor
- UniProtKB:
Q6UXL7 (UniProtKB/Swiss-Prot), Q8NC72 (UniProtKB/Swiss-Prot), Q6UXM1 (UniProtKB/Swiss-Prot)
- Sequence:
MSAPSLRARAAGLGLLLCAVLGRAGRSDSGGRGELGQPSGVAAERPCPTTCRCLGDLLDCSRKRLARLPEPLPSWVARLDLSHNRLSFIKASSMSHLQSLREVKLNNNELETIPNLGPVSANITLLSL AGNRIVEILPEHLKEFQSLETLDLSSNNISELQTAFPALQLKYLYLNSNRVTSMEPGYFDNLANTLLVLKLNRNRISAIPPKMFKLPQLQHLELNRNKIKNVDGLTFQGLGALKSLKMQRNGVTKLMD GAFWGLSNMEILQLDHNNLTEITKGWLYGLLMLQELHLSQNAINRISPDAWEFCQKLSELDLTFNHLSRLDDSSFLGLSLLNTLHIGNNRVSYIADCAFRGLSSLKTLDLKNNEISWTIEDMNGAFSG LDKLRRLILQGNRIRSITKKAFTGLDALEHLDLSDNAIMSLQGNAFSQMKKLQQLHLNTSSLLCDCQLKWLPQWVAENNFQSFVNASCAHPQLLKGRSIFAVSPDGFVCDDFPKPQITVQPETQSAIK GSNLSFICSAASSSDSPMTFAWKKDNELLHDAEMENYAHLRAQGGEVMEYTTILRLREVEFASEGKYQCVISNHFGSSYSVKAKLTVNMLPSFTKTPMDLTIRAGAMARLECAAVGHPAPQIAWQKDG GTDFPAARERRMHVMPEDDVFFIVDVKIEDIGVYSCTAQNSAGSISANATLTVLETPSFLRPLLDRTVTKGETAVLQCIAGGSPPPKLNWTKDDSPLVVTERHFFAAGNQLLIIVDSDVSDAGKYTCE MSNTLGTERGNVRLSVIPTPTCDSPQMTAPSLDDDGWATVGVVIIAVVCCVVGTSLVWVVIIYHTRRRNEDCSITNTDETNLPADIPSYLSSQGTLADRQDGYVSSESGSHHQFVTSSGAGFFLPQHD SSGTCHIDNSSEADVEAATDLFLCPFLGSTGPMYLKGNVYGSDPFETYHTGCSPDPRTVLMDHYEPSYIKKKECYPCSHPSEESCERSFSNISWPSHVRKLLNTSYSHNEGPGMKNLCLNKSSLDFSA NPEPASVASSNSFMGTFGKALRRPHLDAYSSFGQPSDCQPRAFYLKAHSSPDLDSGSEEDGKERTDFQEENHICTFKQTLENYRTPNFQSYDLDT
hide sequence
RefSeq Acc Id:
NP_001129523 ⟸ NM_001136051
- Peptide Label:
isoform 1 precursor
- UniProtKB:
Q6UXM1 (UniProtKB/Swiss-Prot)
- Sequence:
MVDVLLLFSLCLLFHISRPDLSHNRLSFIKASSMSHLQSLREVKLNNNELETIPNLGPVSANITLLSLAGNRIVEILPEHLKEFQSLETLDLSSNNISELQTAFPALQLKYLYLNSNRVTSMEPGYFD NLANTLLVLKLNRNRISAIPPKMFKLPQLQHLELNRNKIKNVDGLTFQGLGALKSLKMQRNGVTKLMDGAFWGLSNMEILQLDHNNLTEITKGWLYGLLMLQELHLSQNAINRISPDAWEFCQKLSEL DLTFNHLSRLDDSSFLGLSLLNTLHIGNNRVSYIADCAFRGLSSLKTLDLKNNEISWTIEDMNGAFSGLDKLRRLILQGNRIRSITKKAFTGLDALEHLDLSDNAIMSLQGNAFSQMKKLQQLHLNTS SLLCDCQLKWLPQWVAENNFQSFVNASCAHPQLLKGRSIFAVSPDGFVCDDFPKPQITVQPETQSAIKGSNLSFICSAASSSDSPMTFAWKKDNELLHDAEMENYAHLRAQGGEVMEYTTILRLREVE FASEGKYQCVISNHFGSSYSVKAKLTVNMLPSFTKTPMDLTIRAGAMARLECAAVGHPAPQIAWQKDGGTDFPAARERRMHVMPEDDVFFIVDVKIEDIGVYSCTAQNSAGSISANATLTVLETPSFL RPLLDRTVTKGETAVLQCIAGGSPPPKLNWTKDDSPLVVTERHFFAAGNQLLIIVDSDVSDAGKYTCEMSNTLGTERGNVRLSVIPTPTCDSPQMTAPSLDDDGWATVGVVIIAVVCCVVGTSLVWVV IIYHTRRRNEDCSITNTDETNLPADIPSYLSSQGTLADRQDGYVSSESGSHHQFVTSSGAGFFLPQHDSSGTCHIDNSSEADVEAATDLFLCPFLGSTGPMYLKGNVYGSDPFETYHTGCSPDPRTVL MDHYEPSYIKKKECYPCSHPSEESCERSFSNISWPSHVRKLLNTSYSHNEGPGMKNLCLNKSSLDFSANPEPASVASSNSFMGTFGKALRRPHLDAYSSFGQPSDCQPRAFYLKAHSSPDLDSGSEED GKERTDFQEENHICTFKQTLENYRTPNFQSYDLDT
hide sequence
RefSeq Acc Id:
XP_016874279 ⟸ XM_017018790
- Peptide Label:
isoform X1
- UniProtKB:
C9K080 (UniProtKB/TrEMBL)
- Sequence:
MSAPSLRARAAGLGLLLCAVLGRAGRSDSGGRGELGQPSGVAAERPCPTTCRCLGDLLDCSRKR LARLPEPLPSWVARLDLSHNRLSFIKASSMSHLQSLREVKLNNNELETIPNLGPVSANITLLSLAGNRIVEILPEHLKEFQSLETLDLSSNNISELQTAFPALQLKYLYLNSNRVTSMEPGYFDNLAN TLLVLKLNRNRISAIPPKMFKLPQLQHLELNRNKIKNVDGLTFQGLGALKSLKMQRNGVTKLMDGAFWGLSNMEILQLDHNNLTEITKGWLYGLLMLQELHLSQNAINRISPDAWEFCQKLSELDLTF NHLSRLDDSSFLGLSLLNTLHIGNNRVSYIADCAFRGLSSLKTLDLKNNEISWTIEDMNGAFSGLDKLRRLILQGNRIRSITKKAFTGLDALEHLDLSDNAIMSLQGNAFSQMKKLQQLHLNTSSLLC DCQLKWLPQWVAENNFQSFVNASCAHPQLLKGRSIFAVSPDGFVCDDFPKPQITVQPETQSAIKGSNLSFICSAASSSDSPMTFAWKKDNELLHDAEMENYAHLRAQGGEVMEYTTILRLREVEFASE GKYQCVISNHFGSSYSVKAKLTVNIPHLTLPFPTFHSTKLRFLVICI
hide sequence
Ensembl Acc Id:
ENSP00000326759 ⟸ ENST00000320743
Ensembl Acc Id:
ENSP00000368436 ⟸ ENST00000379141
Ensembl Acc Id:
ENSP00000449169 ⟸ ENST00000550825
Ensembl Acc Id:
ENSP00000413143 ⟸ ENST00000433272
Ensembl Acc Id:
ENSP00000449109 ⟸ ENST00000552267
RefSeq Acc Id:
XP_054227038 ⟸ XM_054371063
- Peptide Label:
isoform X1
- UniProtKB:
C9K080 (UniProtKB/TrEMBL)
RGD ID: 6790224
Promoter ID: HG_KWN:16022
Type: CpG-Island
SO ACC ID: SO:0000170
Source: MPROMDB
Tissues & Cell Lines: HeLa_S3, K562, Lymphoblastoid
Transcripts: NM_153377, UC009ZQH.1
Position: Human Assembly Chr Position (strand) Source Build 36 12 57,599,631 - 57,600,632 (-) MPROMDB
RGD ID: 7224629
Promoter ID: EPDNEW_H18060
Type: initiation region
Name: LRIG3_2
Description: leucine rich repeats and immunoglobulin like domains 3
SO ACC ID: SO:0000170
Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ )
Alternative Promoters: null; see alsoEPDNEW_H18061
Experiment Methods: Single-end sequencing.
Position: Human Assembly Chr Position (strand) Source GRCh38 12 58,919,505 - 58,919,565 EPDNEW
RGD ID: 7224631
Promoter ID: EPDNEW_H18061
Type: initiation region
Name: LRIG3_1
Description: leucine rich repeats and immunoglobulin like domains 3
SO ACC ID: SO:0000170
Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ )
Alternative Promoters: null; see alsoEPDNEW_H18060
Experiment Methods: Single-end sequencing.
Position: Human Assembly Chr Position (strand) Source GRCh38 12 58,920,490 - 58,920,550 EPDNEW
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2016-06-14
LRIG3
leucine rich repeats and immunoglobulin like domains 3
leucine-rich repeats and immunoglobulin like domains 3
Symbol and/or name change
5135510
APPROVED
2016-03-14
LRIG3
leucine-rich repeats and immunoglobulin like domains 3
leucine-rich repeats and immunoglobulin-like domains 3
Symbol and/or name change
5135510
APPROVED